If global trade isn't going to pull the world economy out of its persistent doldrums, why are countries putting so much political energy into signing these agreements?
Representatives from the CoC and Unifor recently met with Minister Sohi in Edmonton to discuss concerns about the Trans-Pacific Partnership.
Prime Minister Justin Trudeau has been promoting the Canada-European Union Comprehensive Economic and Trade Agreement (CETA) at the G20 summit in Hangzhou, China this weekend.
Rather than accepting half-hearted revisions of Harper's corporate-embracing policies, the Trudeau government should refuse to sign any trade deal with sweeping privileges for foreign investors.
While debate rages in Europe about CETA, the Canada-EU trade agreement, a new report warns that the deal could lower food safety standards.
Thanks to Brexit and the fact that our largest EU trading partner is no longer in CETA, the Council of Canadians is calling on Trudeau to do a proper cost-benefit analysis of CETA.
Elementary logic suggests that deals (they're rarely called "free trade" deals any more) written in secret with only corporate figures present alongside governments will reflect -- guess who?
The TPP prohibits governments from requiring information about drug prices or R&D costs in connection with registration. Who wants to enforce a further lack of knowledge of drug prices or R&D costs?
Health Canada finally acknowledged what health economists, academics and activists had been saying for some time: drug costs will rise under pending trade deals like the TPP.
A new study looks at the latest attempts to reform CETA's Investment Court System and shows how the changes fail to deliver on their promise to prevent controversial trade lawsuits.